Status:
COMPLETED
Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women
Lead Sponsor:
Hatem AbuHashim
Conditions:
Iron Deficiency Anemia of Pregnancy
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
Anemia in pregnancy is defined by the World Health Organization as hemoglobin levels of ≤ 11 g/dl. Globally, a prevalence rate of 38% was estimated by the World Health Organization for pregnant women....
Eligibility Criteria
Inclusion
- Pregnant women aged 20 to 40 years,
- 14-27 gestational weeks calculated from the first day of their last menstrual period and confirmed by ultrasound
- Singleton fetus
- hemoglobin level from 7-9.9 g/dL.
Exclusion
- All women with high risk pregnancy e.g. hypertension, diabetes
- multiple pregnancy
- women with severe anemia (Hb \>7 g/dl)
- anemia due to other causes than iron deficiency as chronic blood loss, hemolytic anemia or thalassemia.
- women with hepatic, renal or cardiovascular abnormality; women with peptic ulcer, esophagitis, gastritis or hiatus hernia
- family history of thalassemia, sickle cell anemia, or malabsorption syndrome
- hypersensitivity to iron preparations or current use of iron supplementation.
Key Trial Info
Start Date :
December 31 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2017
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03378791
Start Date
December 31 2015
End Date
October 31 2017
Last Update
December 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt